- •There are no data to support recommendation for 6-minute walk test (6MWT) termination if oxyhemoglobin saturation <80%.
- •Retrospective audit of tests was conducted in stable patients by experienced clinicians.
- •A total of 672 tests were reviewed; 2 adverse events were recorded during tests without desaturation.
- •Findings do not support 6MWT termination due to desaturation.
Main Outcome Measure
List of abbreviations:6MWT (6-minute walk test), 6MWD (6-minute walk distance), CI (confidence interval), OR (odds ratio), RECORD (REporting of studies Conducted using Observational Routinely-collected health Data), SpO2 (oxyhemoglobin saturation)
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Archives of Physical Medicine and Rehabilitation
- An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease.Eur Respir J. 2014; 44: 1428-1446
- Pulse oximetry oxygen sauration during the 6-min walk test: a limit for stopping the test without resuming it.Eur Respir J. 2015; 46: 1222-1223
- ATS statement: guidelines for the six-minute walk test.Am J Respir Crit Care Med. 2002; 166: 111-117
- Should oxyhaemoglobin saturation be monitored continuously during the 6-minute walk test?.Chron Respir Dis. 2011; 8: 181-184
- The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement.PLoS Med. 2015; 12: e1001885
- Hypoxemia and arrhythmia during daily activities and six-minute walk test in fibrotic interstitial lung diseases.J Korean Med Sci. 2011; 26: 372-378
- Six-minute walk test: observed adverse events and oxygen desaturation in a large cohort of patients with chronic lung disease.Intern Med J. 2011; 41: 416-422
- Serious adverse events during a 6-min walk test in patients with pulmonary hypertension.Eur Respir J. 2015; 45: 1179-1182
- 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).Eur Respir J. 2015; 46: 903-975
- Development of the new lung allocation system in the United States.Am J Transplant. 2006; 6: 1212-1227